Menu
Recruiting NCT06806488

Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

— Observational Marginal Zone B Cell Lymphoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Marginal Zone B Cell Lymphoma. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Retrospective Observational Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

Overview

This is a purely retrospective and observational monocentric study

Detailed description

the study aimed at describing the characteristics and outcome of Marginal zone lymphoma patients who were diagnosed and treated in our Hospital between December 2012 and December 2018

Primary outcome measures

  • clinical characteristics of Marginal zone lymphoma patients [Time frame: through study completion, an average of 1 years]
Secondary outcome measures (2)
  • effectiveness [Time frame: through study completion, an average of 1 years]
  • safety [Time frame: through study completion, an average of 1 years]

Eligibility criteria

Inclusion criteria

  • Marginal zone lymphoma patients who were diagnosed and treated in our Hospital between December 2012 and December 2018.
  • Age ≥ 18 years at enrolment.
  • Written informed consent (if applicable)

Exclusion criteria

  • none

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Italy · 1 center
  • IRCCS Azienda Ospedaliero - Universitaria di Bologna — Bologna

Identifiers

NCT: NCT06806488 · MarZoLyOss

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗